Follow
Carmen Ng
Carmen Ng
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
Changes in the incidence of childhood obesity
SA Cunningham, ST Hardy, R Jones, C Ng, MR Kramer, KMV Narayan
Pediatrics 150 (2), e2021053708, 2022
512022
Biases in self-reported height and weight measurements and their effects on modeling health outcomes
CD Ng
SSM-population health 7, 100405, 2019
342019
In, out, and fluctuating: obesity from adolescence to adulthood
CD Ng, SA Cunningham
Annals of epidemiology 41, 14-20, 2020
252020
Beyond recent BMI: BMI exposure metrics and their relationship to health
CD Ng, MR Elliott, F Riosmena, SA Cunningham
SSM-Population Health 11, 100547, 2020
242020
Persistence and adherence to ocrelizumab compared with other disease-modifying therapies for multiple sclerosis in US commercial claims data
NJ Engmann, D Sheinson, K Bawa, CD Ng, G Pardo
Journal of Managed Care & Specialty Pharmacy 27 (5), 639-649, 2021
192021
Global analysis of overweight prevalence by level of human development
CD Ng
Journal of Global Health 5 (2), 2015
192015
Further results on SD-prime labeling
GC Lau, WC Shiu, HK Ng, CD Ng, P Jeyanthi
JCMCC 98, 151-170, 2016
172016
The association between persistence and adherence to disease-modifying therapies and healthcare resource utilization and costs in patients with multiple sclerosis
G Pardo, ED Pineda, CD Ng, D Sheinson, NG Bonine
Journal of Health Economics and Outcomes Research 9 (1), 111, 2022
132022
The impact of funding inpatient treatments for COVID-19 on health equity in the United States: a distributional cost-effectiveness analysis
S Kowal, CD Ng, R Schuldt, D Sheinson, R Cookson
Value in Health 26 (2), 216-225, 2023
122023
Errors in body mass index from self-reported data by sex and across waves of Add Health
CD Ng
Annals of epidemiology 39, 21-25, 2019
102019
Adherence to and persistence with disease-modifying therapies for multiple sclerosis over 24 months: a retrospective claims analysis
G Pardo, ED Pineda, CD Ng, KK Bawa, D Sheinson, NG Bonine
Neurology and Therapy 11 (1), 337-351, 2022
92022
Stratification of BMI categories among older adults within and across countries
CD Ng
Public health nutrition 23 (2), 254-263, 2020
82020
Estimating the US baseline distribution of health inequalities across race, ethnicity, and geography for equity-informative cost-effectiveness analysis
S Kowal, CD Ng, R Schuldt, D Sheinson, K Jinnett, A Basu
Value in Health 26 (10), 1485-1493, 2023
32023
Association of genetic and behavioral characteristics with the onset of diabetes
CD Ng, J Weiss
BMC Public Health 19, 1-9, 2019
32019
From birth to adulthood: anthropometric trajectories and their implications for chronic diseases in Guatemala
CD Ng
Journal of biosocial science 51 (2), 292-306, 2019
22019
Clinical Outcomes in Patients With Refractory Anemia With Excess Blasts (RAEB) Who Receive Hypomethylating Agents (HMAs)
AM Zeidan, ES Mearns, CD Ng, A Shah, N Lamarre, A Yellow-Duke, ...
Clinical Lymphoma Myeloma and Leukemia 24 (3), 177-186, 2024
12024
US cost-effectiveness analysis of polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma
M Matasar, A Masaquel, R S. Ho, A Launonen, CD Ng, R Wang, D Fox, ...
Journal of Medical Economics 26 (1), 1134-1144, 2023
12023
Assessment of second primary malignancies among treated and untreated patients with chronic lymphocytic leukemia using real-world data from the USA
S Ailawadhi, A Ravelo, CD Ng, B Shah, N Lamarre, R Wang, K Eakle, ...
Journal of Comparative Effectiveness Research 13 (2), e230119, 2024
2024
The Association of Retinal Disease with Vision Impairment and Functional Status in Medicare Patients
V Garmo, X Zhao, CD Ng, A Near, T Banerji, K Wada, G Oderda, D Brixner, ...
Journal of Health Economics and Outcomes Research 11 (1), 94, 2024
2024
Cost of Disease Progression in Diffuse Large B-Cell Lymphoma After Frontline Treatment With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
JM Burke, A Masaquel, R Wang, F Hossain, J Li, SQ Zhou, CD Ng, ...
Clinical Lymphoma Myeloma and Leukemia 23 (11), e393-e404, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20